Changes in arginine are inversely associated with type 2 diabetes: A case-cohort study in the PREDIMED trial

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Changes in arginine are inversely associated with type 2 diabetes : A case-cohort study in the PREDIMED trial. / Yu, Edward; Ruiz-Canela, Miguel; Razquin, Cristina; Guasch-Ferré, Marta; Toledo, Estefania; Wang, Dong D.; Papandreou, Christopher; Dennis, Courtney; Clish, Clary; Liang, Liming; Bullo, Monica; Corella, Dolores; Fitó, Montserrat; Gutiérrez-Bedmar, Mario; Lapetra, José; Estruch, Ramón; Ros, Emilio; Cofán, Montserrat; Arós, Fernando; Romaguera, Dora; Serra-Majem, Lluis; Sorlí, Jose V.; Salas-Salvadó, Jordi; Hu, Frank B.; Martínez-González, Miguel A.

In: Diabetes, Obesity and Metabolism, Vol. 21, No. 2, 2019, p. 397-401.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Yu, E, Ruiz-Canela, M, Razquin, C, Guasch-Ferré, M, Toledo, E, Wang, DD, Papandreou, C, Dennis, C, Clish, C, Liang, L, Bullo, M, Corella, D, Fitó, M, Gutiérrez-Bedmar, M, Lapetra, J, Estruch, R, Ros, E, Cofán, M, Arós, F, Romaguera, D, Serra-Majem, L, Sorlí, JV, Salas-Salvadó, J, Hu, FB & Martínez-González, MA 2019, 'Changes in arginine are inversely associated with type 2 diabetes: A case-cohort study in the PREDIMED trial', Diabetes, Obesity and Metabolism, vol. 21, no. 2, pp. 397-401. https://doi.org/10.1111/dom.13514

APA

Yu, E., Ruiz-Canela, M., Razquin, C., Guasch-Ferré, M., Toledo, E., Wang, D. D., Papandreou, C., Dennis, C., Clish, C., Liang, L., Bullo, M., Corella, D., Fitó, M., Gutiérrez-Bedmar, M., Lapetra, J., Estruch, R., Ros, E., Cofán, M., Arós, F., ... Martínez-González, M. A. (2019). Changes in arginine are inversely associated with type 2 diabetes: A case-cohort study in the PREDIMED trial. Diabetes, Obesity and Metabolism, 21(2), 397-401. https://doi.org/10.1111/dom.13514

Vancouver

Yu E, Ruiz-Canela M, Razquin C, Guasch-Ferré M, Toledo E, Wang DD et al. Changes in arginine are inversely associated with type 2 diabetes: A case-cohort study in the PREDIMED trial. Diabetes, Obesity and Metabolism. 2019;21(2):397-401. https://doi.org/10.1111/dom.13514

Author

Yu, Edward ; Ruiz-Canela, Miguel ; Razquin, Cristina ; Guasch-Ferré, Marta ; Toledo, Estefania ; Wang, Dong D. ; Papandreou, Christopher ; Dennis, Courtney ; Clish, Clary ; Liang, Liming ; Bullo, Monica ; Corella, Dolores ; Fitó, Montserrat ; Gutiérrez-Bedmar, Mario ; Lapetra, José ; Estruch, Ramón ; Ros, Emilio ; Cofán, Montserrat ; Arós, Fernando ; Romaguera, Dora ; Serra-Majem, Lluis ; Sorlí, Jose V. ; Salas-Salvadó, Jordi ; Hu, Frank B. ; Martínez-González, Miguel A. / Changes in arginine are inversely associated with type 2 diabetes : A case-cohort study in the PREDIMED trial. In: Diabetes, Obesity and Metabolism. 2019 ; Vol. 21, No. 2. pp. 397-401.

Bibtex

@article{9c627030f30747f4b1bfe0af84735c47,
title = "Changes in arginine are inversely associated with type 2 diabetes: A case-cohort study in the PREDIMED trial",
abstract = "The associations between arginine-based metabolites and incident type 2 diabetes (T2D) are unknown. We employed a case-cohort design, nested within the PREDIMED trial, to examine six plasma metabolites (arginine, citrulline, ornithine, asymmetric dimethylarginine [ADMA], symmetric dimethylarginine [SDMA] and N-monomethyl-l-arginine [NMMA]) among 892 individuals (251 cases) for associations with incident T2D and insulin resistance. Weighted Cox models with robust variance were used. The 1-year changes in arginine (adjusted hazard ratio [HR] per SD 0.68, 95% confidence interval [CI] 0.49, 0.95; Q4 vs. Q1 0.46, 95% CI 0.21, 1.04; P trend = 0.02) and arginine/ADMA ratio (adjusted HR per SD 0.73, 95% CI 0.51, 1.04; Q4 vs. Q1 0.52, 95% CI 0.22, 1.25; P trend = 0.04) were associated with a lower risk of T2D. Positive changes of citrulline and ornithine, and negative changes in SDMA and arginine/(ornithine + citrulline) were associated with concurrent 1-year changes in homeostatic model assessment of insulin resistance. Individuals in the low-fat-diet group had a higher risk of T2D for 1-year changes in NMMA than individuals in Mediterranean-diet groups (P interaction = 0.02). We conclude that arginine bioavailability is important in T2D pathophysiology.",
keywords = "cohort study, dietary intervention, insulin resistance, observational study, population study, type 2 diabetes",
author = "Edward Yu and Miguel Ruiz-Canela and Cristina Razquin and Marta Guasch-Ferr{\'e} and Estefania Toledo and Wang, {Dong D.} and Christopher Papandreou and Courtney Dennis and Clary Clish and Liming Liang and Monica Bullo and Dolores Corella and Montserrat Fit{\'o} and Mario Guti{\'e}rrez-Bedmar and Jos{\'e} Lapetra and Ram{\'o}n Estruch and Emilio Ros and Montserrat Cof{\'a}n and Fernando Ar{\'o}s and Dora Romaguera and Lluis Serra-Majem and Sorl{\'i}, {Jose V.} and Jordi Salas-Salvad{\'o} and Hu, {Frank B.} and Mart{\'i}nez-Gonz{\'a}lez, {Miguel A.}",
note = "Publisher Copyright: {\textcopyright} 2018 John Wiley & Sons Ltd",
year = "2019",
doi = "10.1111/dom.13514",
language = "English",
volume = "21",
pages = "397--401",
journal = "Diabetes, Obesity and Metabolism",
issn = "1462-8902",
publisher = "Wiley-Blackwell",
number = "2",

}

RIS

TY - JOUR

T1 - Changes in arginine are inversely associated with type 2 diabetes

T2 - A case-cohort study in the PREDIMED trial

AU - Yu, Edward

AU - Ruiz-Canela, Miguel

AU - Razquin, Cristina

AU - Guasch-Ferré, Marta

AU - Toledo, Estefania

AU - Wang, Dong D.

AU - Papandreou, Christopher

AU - Dennis, Courtney

AU - Clish, Clary

AU - Liang, Liming

AU - Bullo, Monica

AU - Corella, Dolores

AU - Fitó, Montserrat

AU - Gutiérrez-Bedmar, Mario

AU - Lapetra, José

AU - Estruch, Ramón

AU - Ros, Emilio

AU - Cofán, Montserrat

AU - Arós, Fernando

AU - Romaguera, Dora

AU - Serra-Majem, Lluis

AU - Sorlí, Jose V.

AU - Salas-Salvadó, Jordi

AU - Hu, Frank B.

AU - Martínez-González, Miguel A.

N1 - Publisher Copyright: © 2018 John Wiley & Sons Ltd

PY - 2019

Y1 - 2019

N2 - The associations between arginine-based metabolites and incident type 2 diabetes (T2D) are unknown. We employed a case-cohort design, nested within the PREDIMED trial, to examine six plasma metabolites (arginine, citrulline, ornithine, asymmetric dimethylarginine [ADMA], symmetric dimethylarginine [SDMA] and N-monomethyl-l-arginine [NMMA]) among 892 individuals (251 cases) for associations with incident T2D and insulin resistance. Weighted Cox models with robust variance were used. The 1-year changes in arginine (adjusted hazard ratio [HR] per SD 0.68, 95% confidence interval [CI] 0.49, 0.95; Q4 vs. Q1 0.46, 95% CI 0.21, 1.04; P trend = 0.02) and arginine/ADMA ratio (adjusted HR per SD 0.73, 95% CI 0.51, 1.04; Q4 vs. Q1 0.52, 95% CI 0.22, 1.25; P trend = 0.04) were associated with a lower risk of T2D. Positive changes of citrulline and ornithine, and negative changes in SDMA and arginine/(ornithine + citrulline) were associated with concurrent 1-year changes in homeostatic model assessment of insulin resistance. Individuals in the low-fat-diet group had a higher risk of T2D for 1-year changes in NMMA than individuals in Mediterranean-diet groups (P interaction = 0.02). We conclude that arginine bioavailability is important in T2D pathophysiology.

AB - The associations between arginine-based metabolites and incident type 2 diabetes (T2D) are unknown. We employed a case-cohort design, nested within the PREDIMED trial, to examine six plasma metabolites (arginine, citrulline, ornithine, asymmetric dimethylarginine [ADMA], symmetric dimethylarginine [SDMA] and N-monomethyl-l-arginine [NMMA]) among 892 individuals (251 cases) for associations with incident T2D and insulin resistance. Weighted Cox models with robust variance were used. The 1-year changes in arginine (adjusted hazard ratio [HR] per SD 0.68, 95% confidence interval [CI] 0.49, 0.95; Q4 vs. Q1 0.46, 95% CI 0.21, 1.04; P trend = 0.02) and arginine/ADMA ratio (adjusted HR per SD 0.73, 95% CI 0.51, 1.04; Q4 vs. Q1 0.52, 95% CI 0.22, 1.25; P trend = 0.04) were associated with a lower risk of T2D. Positive changes of citrulline and ornithine, and negative changes in SDMA and arginine/(ornithine + citrulline) were associated with concurrent 1-year changes in homeostatic model assessment of insulin resistance. Individuals in the low-fat-diet group had a higher risk of T2D for 1-year changes in NMMA than individuals in Mediterranean-diet groups (P interaction = 0.02). We conclude that arginine bioavailability is important in T2D pathophysiology.

KW - cohort study

KW - dietary intervention

KW - insulin resistance

KW - observational study

KW - population study, type 2 diabetes

U2 - 10.1111/dom.13514

DO - 10.1111/dom.13514

M3 - Journal article

C2 - 30146690

AN - SCOPUS:85054304430

VL - 21

SP - 397

EP - 401

JO - Diabetes, Obesity and Metabolism

JF - Diabetes, Obesity and Metabolism

SN - 1462-8902

IS - 2

ER -

ID: 358090574